Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yann Godbert

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 7, 2013
Absolute quantification of left ventricular global and regional function at nuclear MPI using ultrafast CZT SPECT: initial validation versus cardiac MRHubert Cochet, Eric Bullier, Edouard Gerbaud, et al.
Plos One|January 30, 2014
Identification of a recurrent STRN/ALK fusion in thyroid carcinomasGaëlle Pérot, Isabelle Soubeyran, Agnès Ribeiro, et al.
Bulletin Du Cancer|June 16, 2019
The medical treatment of radioiodine-refractory differentiated thyroid cancers in 2019. A TUTHYREF<sup>®</sup> network reviewChristelle de la Fouchardiere, Abir Alghuzlan, Stéphane Bardet, et al.
Endocrine-Related Cancer|October 28, 2020
Limited efficacy of lenvatinib in heavily pretreated anaplastic thyroid cancer: a French overviewClotilde Sparano, Yann Godbert, Marie Attard, et al.
Thyroid : Official Journal of the American Thyroid Association|June 6, 2013
Brain metastases from thyroid carcinoma: a retrospective study of 21 patientsBénédicte Henriques de Figueiredo, Yann Godbert, Isabelle Soubeyran, et al.
Thyroid : Official Journal of the American Thyroid Association|October 20, 2017
Lenvatinib for the Treatment of Radioiodine-Refractory Thyroid Cancer in Real-Life PracticeAmandine Berdelou, Isabelle Borget, Yann Godbert, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 18, 2013
Diagnostic accuracy of 18F-FDG PET/CT for assessing response to radiofrequency ablation treatment in lung metastases: a multicentre prospective studyFrançoise Bonichon, Jean Palussière, Yann Godbert, et al.
Thyroid : Official Journal of the American Thyroid Association|July 3, 2016
Activity and Safety of Sunitinib in Patients with Advanced Radioiodine Refractory Thyroid Carcinoma: A Retrospective Analysis of 57 PatientsVincent Atallah, Arnaud Hocquelet, Christine Do Cao, et al.
Annales D'Endocrinologie|April 27, 2025
ENDOCAN-TUTHYREF network consensus recommendations. Refractory medullary thyroid cancerHélène Lasolle, Christine Do Cao, Livia Lamartina, et al.
Bulletin Du Cancer|October 1, 2021
[Molecular genotyping in refractory thyroid cancers in 2021: When, how and why? A review from the TUTHYREF network]Christelle de la Fouchardière, Johanna Wassermann, Fabien Calcagno, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 7, 2013
Absolute quantification of left ventricular global and regional function at nuclear MPI using ultrafast CZT SPECT: initial validation versus cardiac MRHubert Cochet, Eric Bullier, Edouard Gerbaud, et al.
Plos One|January 30, 2014
Identification of a recurrent STRN/ALK fusion in thyroid carcinomasGaëlle Pérot, Isabelle Soubeyran, Agnès Ribeiro, et al.
Bulletin Du Cancer|June 16, 2019
The medical treatment of radioiodine-refractory differentiated thyroid cancers in 2019. A TUTHYREF<sup>®</sup> network reviewChristelle de la Fouchardiere, Abir Alghuzlan, Stéphane Bardet, et al.
Endocrine-Related Cancer|October 28, 2020
Limited efficacy of lenvatinib in heavily pretreated anaplastic thyroid cancer: a French overviewClotilde Sparano, Yann Godbert, Marie Attard, et al.
Thyroid : Official Journal of the American Thyroid Association|June 6, 2013
Brain metastases from thyroid carcinoma: a retrospective study of 21 patientsBénédicte Henriques de Figueiredo, Yann Godbert, Isabelle Soubeyran, et al.
Thyroid : Official Journal of the American Thyroid Association|October 20, 2017
Lenvatinib for the Treatment of Radioiodine-Refractory Thyroid Cancer in Real-Life PracticeAmandine Berdelou, Isabelle Borget, Yann Godbert, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 18, 2013
Diagnostic accuracy of 18F-FDG PET/CT for assessing response to radiofrequency ablation treatment in lung metastases: a multicentre prospective studyFrançoise Bonichon, Jean Palussière, Yann Godbert, et al.
Thyroid : Official Journal of the American Thyroid Association|July 3, 2016
Activity and Safety of Sunitinib in Patients with Advanced Radioiodine Refractory Thyroid Carcinoma: A Retrospective Analysis of 57 PatientsVincent Atallah, Arnaud Hocquelet, Christine Do Cao, et al.
Annales D'Endocrinologie|April 27, 2025
ENDOCAN-TUTHYREF network consensus recommendations. Refractory medullary thyroid cancerHélène Lasolle, Christine Do Cao, Livia Lamartina, et al.
Bulletin Du Cancer|October 1, 2021
[Molecular genotyping in refractory thyroid cancers in 2021: When, how and why? A review from the TUTHYREF network]Christelle de la Fouchardière, Johanna Wassermann, Fabien Calcagno, et al.
Pageof 4